Pharma Mar, S.A. (BME:PHM)
Spain · Delayed Price · Currency is EUR 70.05
+2.00 (2.94%)
Oct 27, 2026, 12:19 PM CET
Pharma Mar Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 218.64 | 221.39 | 174.86 | 158.15 | 196.34 | 229.83 |
Revenue Growth | 15.52% | 26.61% | 10.56% | -19.45% | -14.57% | -14.87% |
Gross Profit Gross Profit Growth | 204.17 | 209.13 | 166.67 | 148.54 | 182.7 | 213.39 |
Operating Income Operating Income Growth | 38.87 | 60.72 | 6.47 | -3.83 | 42.07 | 92.45 |
Net Income Net Income Growth | 56.13 | 74.99 | 26.13 | 1.14 | 49.36 | 92.86 |
Earnings Per Share EPS Growth | 3.11 | 4.30 | 1.49 | 0.06 | 2.73 | 5.13 |
EPS Growth | 29.14% | 188.68% | 2382.56% | -97.80% | -46.78% | -31.51% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Oncology Oncology Growth | 221.35 | 174.59 | 156.84 | 191.18 | 224.67 |
RNA Interference (RNAi) RNA Interference (RNAi) Growth | 0.04 | 0.26 | 0.12 | 0.03 | 0 |
Total Total Growth | 221.39 | 174.86 | 158.15 | 196.34 | 229.83 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 168.88 | 167.22 | 154.53 | 162.56 | 182.42 | 201.88 |
Total Debt Total Debt Growth | 45.84 | 49.42 | 51.08 | 43.67 | 42.63 | 49.33 |
Net Cash (Debt) Net Cash Growth | 123.04 | 117.81 | 103.45 | 118.89 | 139.79 | 152.55 |
Net Cash Growth | 60.46% | 13.88% | -12.99% | -14.95% | -8.36% | 9.86% |
Net Cash Per Share Net Cash Per Share Growth | 6.81 | 6.75 | 5.89 | 6.64 | 7.74 | 8.44 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 62.21 | 53.13 | 6.03 | -13.45 | 38.32 | 25.68 |
Capital Expenditures CapEx Growth | -8.19 | -6.46 | -15.02 | -14.81 | -8.85 | -7.8 |
Free Cash Flow Free Cash Flow Growth | 54.02 | 46.67 | -8.99 | -28.25 | 29.47 | 17.87 |
Free Cash Flow Growth | 2941.67% | - | - | - | 64.87% | -93.52% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 93.38% | 94.46% | 95.32% | 93.92% | 93.05% | 92.85% |
Operating Margin | 17.78% | 27.42% | 3.70% | -2.42% | 21.43% | 40.22% |
Pretax Margin | 18.66% | 26.94% | 6.85% | -2.29% | 22.30% | 41.39% |
Profit Margin | 25.67% | 33.87% | 14.94% | 0.72% | 25.14% | 40.40% |
FCF Margin | 24.71% | 21.08% | -5.14% | -17.87% | 15.01% | 7.78% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.000 | 1.000 | 0.800 | 0.650 | 0.650 | 0.650 |
Dividend Per Share Growth | 25.00% | 25.00% | 23.08% | 0% | 0% | 8.33% |
Dividend Yield | 1.43% | 1.35% | 1.01% | 1.55% | 1.02% | 1.13% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 22.51 | 17.19 | 53.17 | 649.51 | 23.46 | 11.12 |
Forward PE | 18.17 | 24.03 | 36.29 | 67.76 | 16.74 | 12.76 |
P/FCF Ratio | 21.84 | 27.62 | - | - | 39.30 | 57.78 |
PS Ratio | 5.40 | 5.82 | 7.94 | 4.67 | 5.90 | 4.49 |